[Prevention, iatrogeny, and public health].

Gac Sanit

Pla Interdepartamental de Salut Pública, Secretaria de Salut Pública, Departament de Salut, Generalitat de Catalunya, Barcelona, España. Electronic address:

Published: August 2015

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gaceta.2014.02.002DOI Listing

Publication Analysis

Top Keywords

[prevention iatrogeny
4
iatrogeny public
4
public health]
4
[prevention
1
public
1
health]
1

Similar Publications

[Healthcare professionals' perception of advanced nursing practice in Ehpad with regard to the risk of drug iatrogenicity in heart failure patients].

Soins Gerontol

June 2024

Pôle Gériatrie-SSR, Site de Marne-la-vallée-Ghef, 2-4 cours de la Gondoire, 77600 Jossigny, France. Electronic address:

Medication iatrogenia is a real public health problem. Elderly people are particularly at risk, due to their multiple pathologies, including heart failure; residents of residential care facilities for the dependent elderly (Ehpad) are no exception. Studies show that this risk is avoidable in 60% of cases, and that advanced practice nurses (APNs) can play a pivotal role in preventive measures.

View Article and Find Full Text PDF

The health product circuit corresponds to the chain of steps that a medicine goes through in hospital, from prescription to administration. The safety and regulation of all the stages of this circuit are major issues to ensure the safety and protect the well-being of hospitalized patients. In this paper we present an automatic system for analyzing prescriptions using Artificial Intelligence (AI) and Machine Learning (ML), with the aim of ensuring patient safety by limiting the risk of prescription errors or drug iatrogeny.

View Article and Find Full Text PDF

[Validation of a method for detecting hospitalizations for falls related to adverse drug reactions in geriatric departments].

Geriatr Psychol Neuropsychiatr Vieil

December 2023

Service de Pharmacie, CHU de Caen Normandie, Caen, France, Service de Gériatrie, CHU de Caen Normandie, Caen, France.

Fall is one of the five main causes of drug-related hospital admissions (DRA) in France. A standardized chart review method, to identify DRA adapted to elderly patients, has recently been developed by Thevelin et al. Our first aim was to assess the reliability of this method for detecting DRA for falls in elderly subjects.

View Article and Find Full Text PDF
Article Synopsis
  • Hidradenitis suppurativa (HS) is a chronic skin disease with limited treatments, and adalimumab, a TNF-α monoclonal antibody, is the first approved therapy for moderate to severe cases.
  • A 23-year-old woman on adalimumab for HS developed severe headaches, nausea, and fever two years later, which led to the discovery of isolated neurotuberculosis via MRI and a positive TB test.
  • This case emphasizes the need for regular monitoring and screening for tuberculosis in patients receiving immunosuppressive therapy to catch infections early and avoid serious complications.
View Article and Find Full Text PDF

[Nephroprotection: General principles and application to the patients with cancers - when nephroprotection is essential for oncological care plan].

Bull Cancer

July 2024

Assistance publique-Hôpitaux de Paris (AP-HP), centre hospitalier universitaire de Bicêtre, université de Paris-Saclay, service de néphrologie, dialyse et transplantation, Le Kremlin-Bicêtre, France.

Article Synopsis
  • * Cancer patients face unique risks of renal issues due to specific treatments and are often not adequately represented in nephroprotection studies, leading to gaps in current guidelines.
  • * The article emphasizes adapting nephroprotection strategies for cancer patients, focusing on education, managing comorbidities, and the need for collaboration between oncologists and nephrologists to develop the emerging field of onco-nephrology.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!